A cosmid-based system for inserting mutations and foreign genes into the simian varicella virus genome

Allen, 1974, Recent studies on the isolation and characterization of delta herpesvirus, Lab. Anim. Sci., 24, 222 Arvin, 1999, Development of recombinant varicella-zoster virus vaccines, Contrib. Microbiol., 3, 193, 10.1159/000060324 Cohen, 1993, Generation of varicella-zoster virus (VZV) and viral mutants from cosmid DNAs: VZV thymidylate synthetase is not essential for replication in vitro, Proc. Natl. Acad. Sci. USA, 90, 7376, 10.1073/pnas.90.15.7376 Cunningham, 1993, A cosmid-based system for constructing mutants of herpes simplex virus type 1, Virology, 197, 116, 10.1006/viro.1993.1572 Fletcher, 1992, Simian varicella virus: Characterization of virion and infected cell polypeptides and the antigenic cross-reactivity with varicella-zoster virus, J. Gen. Virol., 73, 1209, 10.1099/0022-1317-73-5-1209 Gray, 2004, Simian varicella: a model for human varicella-zoster virus infections, Rev. Med. Virol., 14, 363, 10.1002/rmv.437 Gray, 2003, Characterization of the simian varicella virus glycoprotein C, which is nonessential for in vitro replication, Arch. Virol., 148, 537, 10.1007/s00705-002-0945-9 Gray, 1992, The simian varicella virus and varicella zoster virus genomes are similar in size and structure, Virology, 186, 562, 10.1016/0042-6822(92)90022-H Gray, 2001, The DNA sequence of the simian varicella virus genome, Virology, 284, 123, 10.1006/viro.2001.0912 Heineman, 2004, Varicella-zoster virus expressing HSV-2 glycoproteins B and D induces protection against HSV-2 challenge, Vaccine, 22, 2558, 10.1016/j.vaccine.2003.12.010 Kemble, 2000, Open reading frame S/L of varicella-zoster virus encodes a cytoplasmic protein expressed in infected cells, J. Virol., 74, 11311, 10.1128/JVI.74.23.11311-11321.2000 Lowe, 1987, Varicella-zoster virus as a live vaccine for the expression of foreign genes, Proc. Natl. Acad. Sci. USA, 84, 3896, 10.1073/pnas.84.11.3896 Mahalingam, 1991, Simian varicella virus DNA in dorsal root ganglia, Proc. Natl. Acad. Sci. USA, 88, 2750, 10.1073/pnas.88.7.2750 Mahalingam, 1998, Infectious simian varicella virus expressing the green fluorescent protein, J. Neurovirol., 4, 438, 10.3109/13550289809114543 Mallory, 2005, Analysis of the glycoproteins I and E of varicella-zoster virus (VZV) using deletional mutations of VZV cosmids, J. Infect. Dis., 178, 22, 10.1086/514277 Moffat, 1998, Attenuation of the vaccine Oka strain of varicella-zoster virus and role of glycoprotein C in alphaherpesvirus virulence demonstrated in the SCID-hu mouse, J. Virol., 72, 965, 10.1128/JVI.72.2.965-974.1998 Niizuma, 2005, Construction of varicella-zoster virus recombinants from parent Oka cosmids and demonstration that ORF65 protein is dispensible for infection of human skin and T cells in the SCID-hu mouse model, J. Virol., 77, 6062, 10.1128/JVI.77.10.6062-6065.2003 Sato, 2002, Varicella-zoster virus open reading frame 2 encodes a membrane phosphoprotein that is dispensible for viral replication and for establishment of latency, J. Virol., 76, 3575, 10.1128/JVI.76.7.3575-3578.2002 Shiraki, 2001, Construction of Oka varicella vaccine expressing human imunodeficiency virus env antigen, J. Med. Virol., 64, 89, 10.1002/jmv.1022 Tang, 1996, In vitro gene delivery by degraded polyamidoamine dendrimers, Bioconjugate Chem., 7, 703, 10.1021/bc9600630 Van Zijl, 1988, Regeneration herpesviruses from molecularly cloned subgenomic fragments., J. Virol., 62, 2191, 10.1128/JVI.62.6.2191-2195.1988